s-adenosylmethionine has been researched along with Kidney Failure, Chronic in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 8 (50.00) | 29.6817 |
2010's | 5 (31.25) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Fukami, K; Ito, S; Kaida, Y; Kinoshita, Y; Kodama, G; Nakayama, Y; Tashiro, K; Yano, J; Yokota, Y | 1 |
Akiba, T; Kamei, D; Mineshima, M; Nitta, K; Tsuchiya, K | 1 |
Clish, CB; Deferio, JJ; Deik, A; Elmariah, S; Gerszten, RE; Kalim, S; Pierce, K; Rhee, EP; Thadhani, R; Wenger, J; Yeh, RW | 1 |
Abe, M; Ando, H; Higuchi, T; Kikuchi, F; Mizuno, M; Oikawa, O; Okada, K; Okawa, E; Soma, M; Yamazaki, T | 1 |
Csiky, B; Melegh, B; Nyul, Z; Rascher, W; Rauh, M; Sulyok, E; Tóth, G; Wittmann, I | 1 |
Davis, AT; Spry, L; Steiber, AL; Weatherspoon, LJ | 1 |
Chace, DH; Evans, AM; Faull, RJ; Fornasini, G; Reuter, SE | 1 |
Fouque, D; Guebre-Egziabher, F; Hadj-Aïssa, A; Holt, S; Hoppel, CL; Kopple, JD; Nakamura, K; Vianey-Saban, C | 1 |
Chan, CT; Fisher, L; Geary, DF; Hothi, DK | 1 |
Adler, S; Amato, A; Brass, EP; Hiatt, WR; Orlando, AM; Sietsema, KE | 1 |
Blom, HJ; Choi, SW; Corrocher, R; Friso, S; Girelli, D; Guarini, P; Martinelli, N; Olivieri, O; Pizzolo, F; Stanzial, AM | 1 |
de Meer, K; Jakobs, C; Kulik, W; Smith, DE; Stam, F; Stehouwer, CD; ter Wee, PM; van Guldener, C | 1 |
Fowler, B; Herrmann, W; Kuhlmann, MK; Makowski, J; Obeid, R; Schorr, H | 1 |
Capasso, G; De Santo, NG; Galletti, P; Ingrosso, D; Perna, AF; Zappia, V | 1 |
Angst, CP; Brunner, FP; Fowler, B; Haefeli, WE; Loehrer, FM | 1 |
Dudman, NP; Fu, W; Perry, MA; Wang, XL; Young, K | 1 |
4 trial(s) available for s-adenosylmethionine and Kidney Failure, Chronic
Article | Year |
---|---|
Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.
Topics: Administration, Oral; Aged; Ankle Brachial Index; Atherosclerosis; Biomarkers; Blood Flow Velocity; Carnitine; Dietary Supplements; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pulsatile Flow; Renal Dialysis | 2014 |
L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
Topics: Adipokines; Aged; Aged, 80 and over; Arteriosclerosis; Carnitine; Female; Humans; Infusions, Intravenous; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors | 2010 |
Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
Topics: Adult; Aged; Carbon Dioxide; Carnitine; Double-Blind Method; Exercise Test; Exercise Tolerance; Fatigue; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Models, Biological; Oxygen Consumption; Quality of Life; Renal Dialysis | 2001 |
Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia.
Topics: Adult; Aged; Dietary Supplements; DNA Methylation; Folic Acid; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Vitamin B Complex | 2011 |
12 other study(ies) available for s-adenosylmethionine and Kidney Failure, Chronic
Article | Year |
---|---|
Kinetics of Serum Carnitine Fractions in Patients with Chronic Kidney Disease Not on Dialysis.
Topics: Adult; Aged; Amino Acids; Carnitine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Renal Insufficiency, Chronic; Urea; Uric Acid | 2021 |
Association between resistance to erythropoiesis-stimulating agents and carnitine profile in patients on maintenance haemodialysis.
Topics: Adult; Aged; Anemia; Biomarkers; Carnitine; Chromatography, Liquid; Cross-Sectional Studies; Drug Resistance; Female; Hematinics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors; Tandem Mass Spectrometry; Treatment Outcome | 2018 |
A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Carnitine; Case-Control Studies; Chi-Square Distribution; Chromatography, Liquid; Female; Humans; Kidney Failure, Chronic; Logistic Models; Male; Mass Spectrometry; Metabolomics; Middle Aged; Multivariate Analysis; Odds Ratio; Prospective Studies; Renal Dialysis; Risk Factors; Time Factors; Treatment Outcome; Uremia | 2013 |
Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients.
Topics: Age Factors; Blood Urea Nitrogen; Carnitine; Diabetes Complications; Diabetes Mellitus; Female; Humans; Kidney Failure, Chronic; Male; Mannitol; Middle Aged; Parathyroid Hormone; Renal Dialysis; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease.
Topics: Adolescent; Adult; Aged; Carnitine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spectrometry, Mass, Electrospray Ionization | 2005 |
Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease.
Topics: Adult; Carnitine; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 2006 |
Short-term effects of nocturnal haemodialysis on carnitine metabolism.
Topics: Adult; Biological Factors; Carnitine; Circadian Rhythm; Colorimetry; Disease Progression; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Prospective Studies; Renal Dialysis; Time Factors | 2006 |
Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
Topics: Adult; Aged; Case-Control Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Sulfur | 2004 |
Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Topics: Aged; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Methionine; Methylmalonic Acid; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Transcobalamins; Vitamin B 12; Vitamin B 6 | 2005 |
Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.
Topics: Adolescent; Adult; Aged; Child; Erythrocyte Membrane; Erythrocytes; Esterification; Female; Humans; Kidney Failure, Chronic; Male; Membrane Proteins; Methylation; Middle Aged; Models, Biological; Protein O-Methyltransferase; S-Adenosylhomocysteine; S-Adenosylmethionine; Urea | 1993 |
Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?
Topics: Adult; Aged; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Middle Aged; Models, Biological; Renal Dialysis; S-Adenosylhomocysteine; S-Adenosylmethionine | 1998 |
Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
Topics: Adult; Aged; Animals; Case-Control Studies; Chromatography, High Pressure Liquid; Erythrocytes; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Time Factors; Tissue Distribution; Vascular Diseases | 2000 |